This is a randomized, double-blind, placebo-controlled parallel group outpatient study that
will utilize standard stroke rehabilitation outcome measures, as well as fMRI techniques in a
subset of subjects, to evaluate the effect of HT-3951 on motor recovery and behavior in
medically stable subjects following ischemic stroke.